Repare Therapeutics Inc

$33.68 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Join the waitlist

About Repare Therapeutics Inc

Repare Therapeutics Inc is a Canada-based precision oncology company targeting specific vulnerabilities of tumors in genetically defined patient populations. Its approach integrates discoveries from several fields of cell biology including deoxyribonucleic acid (DNA) repair and synthetic lethality. Its SNIPRx platform combines a clustered regularly interspaced short palindromic repeats (CRISPR)-enabled gene editing target discovery method with protein crystallography, computational biology and clinical informatics.

Stock Analysis

last close $34.05
1-mo return 20.1%
3-mo return -18%
avg daily vol. 143.41T
52-week high 46.44
52-week low 21.45
market cap. $1.1B
forward pe -
annual div. -
roe -44.4%
ltg forecast -
dividend yield -
annual rev. $0M
inst own. 82.9%

Join the waitlist for early access and a chance to earn $50 in free stock

Join the waitlist